Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-05-26Clinical Trial Update: Effects of Chocolate on Motor Symptoms of Parkinson's Disease [NA]
This clinical trial explores whether chocolate has an effect on motor symptoms in Parkinson's disease, but no phase or status information is…
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease
This document reports on a completed pilot randomized controlled trial evaluating group visits for people with Parkinson's disease, includin…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa [Phase 2]
Phase 2 study evaluating AFQ056 for reducing L-dopa-induced dyskinesias in Parkinson's disease and its safety when used with L-dopa; the tri…
-
CLINICAL_TRIALS trial_result · 2010-04-29Clinical Trial Update: COMT Polymorphism and Entacapone Efficacy [Phase 4]
A Phase 4 trial assessing whether COMT gene polymorphisms influence the efficacy of entacapone in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-21Clinical Trial Update: Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 [Phase 3]
Long-term extension study evaluating extended-release ropinirole in Parkinson disease patients who completed prior Phase 3 trials; results f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-15Clinical Trial Update: Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients [Phase 3]
A Phase 3 trial comparing extended-release and immediate-release pramipexole to placebo in early Parkinson disease, assessing efficacy, safe…
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine [Phase 3]
A Phase 3 randomized trial evaluating the 24-hour efficacy of Rotigotine for Parkinson's disease has completed, with results posted in 2010.…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease [Phase 3]
This entry reports the long-term extension results of the RECOVER study evaluating 24-hour transdermal rotigotine in idiopathic Parkinson's …
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Rasagiline for Gait Treatment
Clinical trial update on using rasagiline to improve gait in Parkinson disease. No results have been reported yet.
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease
The SEDPARK1 trial assessed the safety and efficacy of piribedil, a non-ergot dopamine agonist, in Parkinson's disease and has completed.
-
FDA approval · 2010-03-29FDA Approved: BENZTROPINE MESYLATE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc. for the original application of benztropine mesylate as a generic product.
-
CLINICAL_TRIALS research · 2010-03-25Clinical Trial Update: Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale
An update on an Italian validation study of the revised MDS-Unified Parkinson's Disease Rating Scale for Parkinson's disease.
-
FDA approval · 2010-03-24FDA Approved: ROPINIROLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original ANDA for ropinirole, a generic version of a dopamine agonist used to treat Parkinson…
-
CLINICAL_TRIALS research · 2010-03-18Clinical Trial Update: Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
A clinical trial update describes using DaTSCAN (ioflupane I-123) together with FDG-PET imaging to assess brain function in first-degree rel…
-
CLINICAL_TRIALS trial_result · 2010-03-18Clinical Trial Update: Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
A clinical trial update evaluating brain function in Parkinson's disease patients with different genetic characteristics using DaTSCAN imagi…
-
CLINICAL_TRIALS research · 2010-03-10Clinical Trial Update: Effectiveness of Physiotherapy Interventions for Patients With Parkinson's Disease [NA]
This entry provides an update on a clinical trial evaluating physiotherapy interventions for Parkinson disease, sponsored by Queen Elizabeth…
-
CLINICAL_TRIALS trial_result · 2010-03-09Clinical Trial Update: Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy. [Phase 3]
Phase 3 trial evaluating rasagiline in advanced Parkinson's disease patients with motor fluctuations receiving levodopa/carbidopa; the study…
-
CLINICAL_TRIALS trial_result · 2010-03-09Clinical Trial Update: Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations [Phase 3]
A multicenter Phase 3 trial evaluated rasagiline in Parkinson's disease patients on levodopa with motor fluctuations; the study has complete…
-
CLINICAL_TRIALS research · 2010-03-09Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating the safety and tolerability of rasagiline in advanced Parkin…
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment
A completed clinical trial assessing non-motor depressive symptoms in Parkinson disease patients treated with pramipexole, with results post…
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin [Phase 1, Phase 2]
Clinical trial update for extended intraputaminal infusion of Liatermin (r-metHuGDNF) in idiopathic Parkinson's disease patients who complet…
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study [NA]
This completed clinical trial update describes a PET imaging study investigating motor activation in individuals with Multiple System Atroph…
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease. [Phase 3]
Open-label extension trial evaluating the safety of long-term rotigotine treatment in early-stage Parkinson's disease; the study completed a…
-
FDA approval · 2010-02-25FDA Approved: ROPINIROLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for ropinirole, enabling a generic version of the drug. Ropinirole is used to treat Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Pivotal Study in Advanced Parkinsons Disease Patients [Phase 3]
Boehringer Ingelheim reports completion and posting of results from a pivotal Phase 3 trial in advanced Parkinson disease.